Lumax Auto Q2: consolidated PAT up 50% YoY to ₹116.7 Cr, margin cools off Q1's 15.1%
PAT +50.43% YoY · revenue +34.52% · margins expanding · beat vs street
₹1,555.51 Cr
+34.52% YoY
₹116.67 Cr
+50.43% YoY
7.41%
+0.8pp YoY
₹15.48
Lumax Auto Technologies' consolidated revenue grew 34.5% YoY (14.1% QoQ) to ₹1,555.5 Cr, and consolidated PAT rose 50.4% YoY (18.3% QoQ) to ₹116.7 Cr (₹105.5 Cr attributable to owners, up 57.8% YoY) — comfortably ahead of both our pre-result preview's expectation (revenue ₹1,400–1,450 Cr, PAT ₹80–90 Cr) and the FY27 full-year consensus run-rate (analyst estimates imply roughly ₹1,613 Cr revenue and ₹111 Cr PAT per quarter; no single-quarter Q2 consensus was published given Lumax's thin sell-side coverage, a risk our preview itself flagged). No exceptional items feature in either the standalone or consolidated statement this quarter, so the growth is on a clean, comparable base — there is no raw-vs-adjusted distinction to draw.
Q2 FY-2027 vs prior quarters
The net-margin story is unambiguously positive: NPM expanded to 7.41% of total income, up from 6.62% a year ago and 7.15% last quarter. But the EBITDA line tells a more mixed story — by our calculation (PBT + depreciation + finance costs, which reconciles to the company's own reported Q1 EBITDA of ₹205 Cr/15.1% margin), Q2 EBITDA margin works out to roughly 14.7%, a step down from Q1's 15.1% and below the lower end of our preview's 15.0–15.5% expected band. Management's prior guidance was explicitly to "sustain Q1 levels for the rest of the year" — on that specific metric, this quarter is a modest miss even as revenue and the bottom line both beat; the gap sits in the cost lines between EBITDA and PBT (materials, employee cost, or other expenses growing slightly faster than revenue), since depreciation and finance costs rose only in line with the capex build-out.
The stock went into the print at ₹1,807.7, down 14.6% over the past month of trading.
For context: this is the highest quarterly PAT in the last 6 quarters on our records; PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.
What the summary numbers don't show
EPS (basic, consolidated) ₹15.48 vs ₹9.81 YoY and ₹12.71 QoQ
No exceptional items this quarter, unlike FY26's annual results which carried labour-code and stake-sale impairment charges
FY27 EBITDA margin 15.1%, sustain Q1 levels for rest of year. FY27 capex ₹300 Cr to fund Mechatronics plant consolidation and IAC expansion. Long-term 20% revenue CAGR 2025–2031; target ₹10,000 Cr revenue by FY31 with ~20% EBITDA margin.
— This quarter: missed
The board paired the results with a new ₹150 Cr Mechatronics manufacturing facility at Manesar (targeting ~₹500 Cr peak annualised turnover, commissioning in two phases from Q3 FY28, debt-and-accrual funded) and the relocation of an existing Aurangabad plant to Chhatrapati Sambhajinagar — both consistent with the FY27 ₹300 Cr capex plan and the longer-term ₹10,000 Cr FY31 revenue target disclosed on the last concall. It also approved an incremental ₹15 Cr corporate guarantee for 60%-owned Lumax Greenfuel Energy Solutions, continuing to fund that subsidiary's capex/working-capital needs. No standalone management press release was available in this context to cross-check against the board's own framing of the quarter.
W1
EBITDA margin trajectory: slipped to ~14.7% in Q2 from Q1's 15.1% against a guided ~15.1% "sustain" target — watch for H2 re-acceleration toward the guided band
W2
Mechatronics plant capex (₹150 Cr, Manesar) layering onto the IAC Chakan (₹156 Cr) build-out within the FY27 ₹300 Cr capex envelope — watch funding mix (debt vs accruals) and near-term leverage
W3
Lumax Greenfuel Energy corporate guarantee now raised by ₹15 Cr this quarter — watch whether guarantee/support quantum to this subsidiary keeps growing
Figures in Lakhs converted to Cr. No exceptional items this quarter (row blank in filing) — unlike FY26 annual results, which carried labour-code and subsidiary-stake-sale exceptional charges. Consolidated PAT ₹116.67 Cr splits ₹105.51 Cr to owners and ₹11.16 Cr to non-controlling interest (Lumax is not 100%-owned in several subsidiaries); EPS is computed on the owners-only figure.
Record growth masks margin compression and deceleration ahead
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Q2 numbers matched guidance closely (₹1,556 Cr vs ₹1,555.5 delivered). EBITDA margin guidance (prior 15.1%) not formally lowered but compressed to 14.7%, margin recovery dependent on assumption.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Lumax delivered 35% revenue growth and 50% PAT growth in Q2, exceeding many expectations, driven by Mechatronics momentum and strong order visibility. However, EBITDA margin compressed 20 bps QoQ to 14.7% despite pricing actions, and management guided H2 growth to 15–20% (decelerating from H1's 34%), signalling cost inflation absorption challenges and demand moderation. Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.
₹1555.5 Cr
Revenue · +34.5% YoY₹116.7 Cr
Reported PAT · +50.4% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Q2 FY27 revenue ₹1,556 Cr, up 35% YoY
METDelivered ₹1,555.5 Cr, up 34.5% YoY
Q2 PAT ₹117 Cr, up 50% YoY
METDelivered ₹116.7 Cr, up 50.4% YoY
Q2 EBITDA ₹228 Cr at 14.7% margin, stable QoQ
OVERSTATEDQ2 reported OPM 13.5%, NPM 7.4%; Q1 margin 14.9%, implies QoQ decline
Aftermarket grew 9% YoY in H1
METAftermarket revenue H1 FY27 ₹234 Cr vs H1 FY26 ₹216 Cr = 8.3% growth, below historical pace
H2 FY27 growth expected 15–20% YoY
UnverifiedImplied guidance, lower than H1 34% delivered; suggests deceleration ahead
Earnings quality
What changed since the last call
Mechatronics acceleration & new plant capex
UpgradePrior call: Mechatronics 22% EBITDA contribution. Now: 27% of order book, ₹150 Cr new plant capex approved for Manesar. Expected ₹500 Cr post-commission revenue at scale, vs implied ₹1,000–1,100 Cr by FY31 (material upgrade in scale ambition).
Margin guidance QoQ compression
DowngradePrior Q1 call: 15.1% EBITDA margin guidance. Q2 delivered 14.7%, down 20 bps QoQ. Management reaffirmed 14.7% is 'broadly stable' but H2 margin recovery assumed, not proven.
H2 revenue growth deceleration guidance
DowngradeH1 delivered 34% growth; management guided H2 to 15–20% YoY growth, a significant moderation, citing higher base and macro headwinds.
Aftermarket growth weakness
DowngradeAftermarket 9% growth in H1 vs prior double-digit growth. Input costs and demand softness cited; management expects 'modest improvement' but 15–20% growth target (not 20%+ prior expectation).
The Q&A
Analysts pressed hard on guidance revision (Amit Hiranandani: 'Are we revising upward after 34% growth?'). Management held firm: 20–25% FY27 full-year growth, no upward revision. Several probed margin sustainability and timing of cost recovery (Raksha Srivastava, Apurva Mehta); management detailed max 1-quarter lag and claimed confidence in full recovery. Deep Shah questioned North Star guidance consistency; management clarified FY25 base and reaffirmed 20% CAGR achievable organically. Overall, management held guidance despite strong delivery, suggesting cautious outlook on sustainability.
Guidance revision post-growth — Amit Hiranandani, PhillipCapital
DodgedNo, we expect full-year 20–25% growth (₹6,000 Cr implied). H1 25% growth, H2 will moderate due to higher base from FY26.
Mechatronics content per vehicle — Radha, Motilal Oswal
PartialCurrently ₹70,000–₹75,000 per PV across product portfolio. Expected to grow by ~10% over 2–3 years as new products scale.
Cost pass-through timing — Raksha Srivastava, Narnolia Financial Services
AnsweredMost recoveries happen same quarter or max 1Q lag. Showing 30–40 bps margin dilution due to lag. Confident to recover in subsequent quarters.
North Star CAGR guidance clarity — Deep Shah, New Vernon Capital
Answered20% CAGR is from FY25 base. For FY27, 20–25% expected. Industry growing 12–15%; we outperform. If we inorganic, CAGR exceeds 20%.
Mechatronics margin trajectory — Apurva Mehta, AM Investments
AnsweredMechatronics margins currently in line with Lumax overall (14–15%). Long-term aspiration 15–18% as scale reaches critical mass and fixed costs absorb.
BCM orders and OEM identity — Amit Hiranandani, PhillipCapital
Partial₹250 Cr order book locked. Technology from large Japanese auto-component maker (not OEM). Standalone revenue, all profitability stays with Lumax.
Guidance
FY27 full-year: 20–25% YoY growth expected (from implied ₹6,000 Cr base of FY26 ₹5,000 Cr)
MediumH1 delivered 34% growth; H2 expected 15–20% due to higher comparison base and macro uncertainty. Management guided to 20–25% at year start.
H2 FY27: 15–20% YoY growth (moderation from H1 34%)
MediumHigher base from FY26 H2 growth; supply-chain inflation expected to persist; demand momentum will be key monitor.
FY31 (long-term): ₹11,000 Cr revenue (20% CAGR from FY25 base of ~₹3,000 Cr)
LowAspiration target. Requires 20% CAGR for 6 years; dependent on organic growth (claimed 15% achievable) plus inorganic (5–7% assumed).
FY27: EBITDA margin ~14.7% (no formal revised guidance, but QoQ showed 14.9% → 14.7% compression)
MediumPrior call guided 15.1%; current quarter 14.7%. Margin recovery dependent on assumption of full cost pass-through to OEMs in subsequent quarters.
FY28: Absolute EBITDA ₹1,000 Cr (implies ~15% margin if 6,500–6,700 Cr revenue assumed)
MediumManagement confident of FY28 EBITDA guidance. Margin recovery in FY28 contingent on cost stability and Mechatronics scaling.
Long-term (FY31): Target ~20% EBITDA margin (range 17–20% mentioned)
LowAspiration. Requires structural margin expansion as Mechatronics and high-margin new products scale (BCM, EV components). No binding commitment.
FY27 capex: ₹300 Cr (H1 ₹60 Cr incurred; remaining ₹240 Cr in H2)
HighAllocation: Mechatronics Manesar plant (~₹150 Cr), Greenfield Nashik ferrule-less expansion, IAC capacity.
Risks the call surfaced
Margin recovery timing
HighEBITDA margin compressed 20 bps QoQ (14.9% to 14.7%) despite claimed cost pass-through. Management cites max 1Q lag, but recovery unproven. If delayed beyond Q3, full-year margin guidance at risk.
Customer concentration
HighAdvanced Plastics is 44% of ₹1,879 Cr order book. OEM concentration risk (passenger vehicle segment). If PV demand slows or a major OEM reduces orders, material revenue impact.
Aftermarket demand softness
MediumAftermarket grew only 9% in H1 FY27 vs prior double-digit growth. Input cost headwinds and softening replacement demand cited. If trend persists, will weigh on overall growth and profitability.
Mechatronics execution risk
Medium₹150 Cr capex approved for new Manesar Mechatronics plant; SOP expected H2 FY28 with ₹500 Cr peak revenue potential. Delays or cost overruns could derail FY28–FY29 revenue and margin targets.
EV product strategy uncertainty
MediumEV component strategy narrowed to 3–5 product categories. No major OEM wins or confirmed orders disclosed. If market adoption slower than expected or competition intense, revenue ramp could be delayed.
Management
Score 7/10. Clear on strategy and numbers; transparent on segment performance and challenges (Aftermarket weakness, cost pressures). Evasive on BCM partner identity and BCM product details. Some deflection when pressed on guidance upward revisions. Strong H1 FY27 delivery: 34% revenue growth, 50% PAT growth. Guided FY27 to 20–25%, implying moderation. FY28 ₹1,000 Cr EBITDA target stated with confidence but unproven. Margin recovery track record weak (14.7% vs 15.1% prior guidance).
1 · Q3 FY27
Greenfuel ferrule-less tubes production ramp for Mahindra/Maruti CNG vehicles
2 · H2 FY28
Mechatronics Manesar plant SOP; BCM (Body Control Module) production scale-up from Japanese partner
3 · FY28
FY28 EBITDA ₹1,000 Cr (absolute) guidance to be tested; margin recovery assumption
Long-term 20% CAGR to ₹11,000 Cr has concrete capex backing (₹300 Cr FY27, new Mechatronics plant, Greenfield), but near-term margin recovery is uncertain and LIL/Aftermarket remain soft.
Can momentum carry through? Lumax Auto's growth streak faces seasonal test
After a stellar Q1 FY27—33% revenue growth and 83% profit jump—LUMAX AUTO reports Q2 on October 24. Analysts broadly bullish on the trajectory, but execution and margin sustainability in the seasonally softer second quarter are the real watch.
What to Expect
LUMAX AUTO set a high bar in Q1 FY27 (ended Jun 2026) with consolidated revenue of ₹1,364 Cr (+33% YoY) and PAT of ₹99 Cr (+83% YoY). EBITDA surged 51% to ₹205 Cr, margin expanding to 15.1%. For Q2 FY27 (ended Sep 2026), expect growth to moderate sequentially—Q2 is seasonally softer in auto—but remain solidly positive on trajectory. The Street anticipates revenue in the ₹1,400–₹1,450 Cr range, with EBITDA margins holding at 15%+. The real test: can the company sustain the 83% profit leverage seen in Q1, or does seasonal demand reset settle margins closer to the low-15% band?
~₹1,400–₹1,450 Cr
Sequential moderation expected; YoY still ~25–30% growth implied
15.0–15.5%
Management guided to maintain current levels; FY27 target 20% mid-term
~₹80–90 Cr
Lower base effect post Q1's 83% surge; profit growth still double-digit expected
Volume & pricing
Auto demand trends + luxury/comfort content penetration (IAC division scaling)
A strong Q2 would show: revenue ₹1,450 Cr+, EBITDA margin 15.5%+, and commentary signalling consistent order flow into H2. A weak print would flag: revenue below ₹1,380 Cr, margin compression below 14.5%, or guidance pullback on FY27 full-year growth assumptions.
On Track with Guidance
LUMAX AUTO raised FY2026 revenue growth guidance from 20% to 25% mid-year, signalling momentum. For FY27, management targets 20% revenue CAGR (2025–2031) and 20% EBITDA margin / 20% ROCE mid-term. Q1's +33% revenue and +51% EBITDA growth significantly outpaced the 25% FY26 raise, suggesting either (a) demand surprise, or (b) tough prior-year base (Q1 FY26: ₹1,026 Cr). Q2 will clarify whether the outperformance holds or normalizes. For now, the quarter-to-date run suggests the company is on track for a 25–28% FY27 growth rate—above the long-term 20% target, which supports the equity story but also raises expectations for consistent execution.
Since Last Quarter
1 · New IAC Manufacturing Plant (Aug 10)
Board approved ₹156 Cr capex for a new Intelligent Ambient Comfort (HVAC/climate control) plant in Chakan, Maharashtra. Ramp-up will support OEM electrification and premiumization trends. Watch: commissioning timeline and ramp capacity—this is a multi-year margin story if demand tracks.
2 · JV Divestment Completed (Jun 30)
Lumax sold its 50% stake in Lumax Jopp Allied Technologies (India-Germany JV) to partner Jopp Holding GmbH. One-time P&L impact likely in Q2 (if recognized). Long-term: frees capital and simplifies operations, but watch for any restructuring charges.
3 · Senior Management Changes (Jul–Sep)
Two superannuations approved (Sep 25); Sunil Koparkar elevated to Senior Management as IAC CEO (Jul 22). Routine governance—no red flags, but signals continued investment in divisional leadership as IAC scales.
4 · Dividend & Shareholder Returns
FY26 dividend of ₹5.50 per share (275% payout) approved and paid. Record date Aug 6; AGM held Aug 26. No special announcements; payout ratio in line with policy.
5 · Trading Window Closure (Sep 25)
Standard closure from Oct 1 until 48 hours post-Q2 result. No insider trading signals observed in public filings.
What to Watch on Result Day (Oct 24)
1 · Margin Resilience
Did EBITDA margin hold at 15%+ despite seasonal H2 softness? Q1's 15.1% was exceptional; hold vs. 14–14.5% would validate the 20% mid-term target credibility.
2 · IAC Division Commentary
Breakout on IAC revenue, margins, and order book. This is the growth story—EV adoption and comfort content will drive it. Watch guidance on Chakan plant ramp and FY27 IAC growth rate.
3 · FY27 Guidance Clarity
Will management confirm 25%+ growth for FY27, or signal moderation? Q2 print + commentary will set expectations for H2 and full-year track.
4 · JV Divestment Impact
One-time gain/loss from Jopp sale. Detail the P&L hit (if any) and clarify normalized Q2 profitability for fair comparison to Q1 run-rate.
5 · FII/DII Flows
Ownership has shifted modestly: FII +31 bps Q1 YoY (now 8.69%), DII stable ~16.5%. Post-result, watch for momentum in foreign flows if growth story re-rates higher.
LUMAX AUTO's Q1 FY27 was a breakout—33% revenue, 83% profit growth, and margin expansion in a softening auto cycle showed both secular (EV, comfort content) and cyclical tailwinds. Q2 will be more grounded: seasonal moderation is normal, but the test is whether the company can hold 15%+ EBITDA margins and deliver 25–30% YoY revenue growth. Analysts remain firmly bullish (Strong Buy, ₹2,000–₹2,304 targets), but at 20x earnings, there is little room for a miss. Watch for margin stability, IAC traction, and any management commentary on order flow into H2—that will set the tone for the stock into year-end.
Result day catalyst: Oct 24, after market close.